July 2, 2026
Authors: Eva D'Amico, PhD - Principal Scientist, Cell Therapy Innovation Mélanie Duyck, PhD - ...
March 17, 2026
A strategic financial analysis of iPSC-based manufacturing vs. autologous models
March 13, 2026
A co-development case from Cellistic & Quell Therapeutics Author: Cécile Augereau, PhD – ...
December 12, 2025
Abstract As cell therapies move from research toward clinical use, the shift from exploratory ...
December 11, 2025
Cellistic participates in this year’s ISSCR PSC-Derived Symposium, a gathering for innovators ...
November 3, 2025
Allogeneic iPSC-derived therapies hold immense promise, offering scalable, off-the-shelf ...
